Renaissance Technologies - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 57 filers reported holding AGILE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$130,000
+62.5%
621,200
+281.3%
0.00%
Q4 2021$80,000
+128.6%
162,900
+341.6%
0.00%
Q3 2021$35,000
-96.8%
36,885
-95.6%
0.00%
-100.0%
Q2 2021$1,111,000
+39.2%
835,559
+117.8%
0.00%0.0%
Q1 2021$798,000
+99.0%
383,611
+166.0%
0.00%
Q2 2020$401,000
-78.3%
144,221
-85.5%
0.00%
-100.0%
Q1 2020$1,847,000
-77.4%
992,746
-69.6%
0.00%
-66.7%
Q4 2019$8,164,000
+183.9%
3,265,601
+34.5%
0.01%
+200.0%
Q3 2019$2,876,000
-12.6%
2,427,100
+7.7%
0.00%
-33.3%
Q2 2019$3,291,000
+2.1%
2,254,180
+5.6%
0.00%0.0%
Q1 2019$3,222,000
+188.2%
2,133,777
+10.0%
0.00%
+200.0%
Q4 2018$1,118,000
+149.0%
1,940,677
+58.6%
0.00%
Q3 2018$449,000
-71.0%
1,223,897
-1.5%
0.00%
-100.0%
Q2 2018$1,548,000
+33.9%
1,242,690
+176.3%
0.00%0.0%
Q1 2018$1,156,000
+17.4%
449,700
+22.8%
0.00%0.0%
Q4 2017$985,000
+149.4%
366,100
+313.7%
0.00%
Q3 2017$395,000
+262.4%
88,500
+161.1%
0.00%
Q1 2017$109,000
-70.1%
33,900
-47.0%
0.00%
-100.0%
Q4 2016$365,000
+153.5%
64,000
+209.2%
0.00%
Q3 2016$144,000
-63.1%
20,700
-54.4%
0.00%
-100.0%
Q2 2015$390,000
+6.0%
45,410
+14.5%
0.00%0.0%
Q1 2015$368,00039,6640.00%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
CAXTON CORP 2,123,567$12,104,00041.30%
ProQuest Associates IV LLC 5,062,363$28,856,0008.17%
Vivo Capital, LLC 1,513,975$8,630,0002.84%
Aisling Capital LLC 1,804,933$10,288,0002.39%
INVESTOR AB 3,510,189$20,008,0001.46%
AlpInvest Partners B.V. 27,693$158,0000.56%
Cormorant Asset Management, LP 563,880$3,214,0000.43%
PURA VIDA INVESTMENTS, LLC 164,501$938,0000.34%
Perceptive Advisors 661,446$3,770,0000.27%
NEEDHAM INVESTMENT MANAGEMENT LLC 140,000$799,0000.20%
View complete list of AGILE THERAPEUTICS INC shareholders